Interaction of dopa decarboxylase from swine kidney with thiosemicarbazone
Minelli, A.; Borri-Voltattorni, C.
Bollettino della Societa Italiana di Biologia Sperimentale 50(12): 852-855
1974
ISSN/ISBN: 0037-8771 PMID: 4475594 Document Number: 75605
Document emailed within 1 workday
Related Documents
Bergonzi, P.; Chiurulla, C.; Gambi, D.; Mennuni, G.; Pinto, F. 1975: L-dopa plus dopa-decarboxylase inhibitor. Sleep organization in Parkinson's syndrome before and after treatment Acta Neurologica Belgica 75(1): 5-10Guillard, A. 1972: Treatment of Parkinson syndromes with L-Dopa and the association of L-Dopa and a decarboxylase inhibitor Bruxelles Medical 52(10): 673-680
Gauthier, G.; de Ajuriaguerra, J.; Geissbuhler, F.; Simona, B.; Constantinidis, J.; Yanniotis, G.; Krassoievitch, M.; Eisenring, J.J.; Tissot, R. 1971: Substitutive therapy in Parkinson's syndromes. L-dopa plus peripheral decarboxylase inhibitor or 3-0-methyl dopa? La Presse Medicale 79(3): 91-92
Blair, M.L.; Reid, I.A.; Ganong, W.F. 1977: Effect of L-dopa on plasma renin activity with and without inhibition of extracerebral dopa decarboxylase in dogs Journal of Pharmacology and Experimental Therapeutics 202(1): 209-215
Pontiroli, A.E.; Castegnaro, E.; Vettaro, M.P.; Viberti, G.C.; Pozza, G. 1977: Stimulatory effect of the dopa-decarboxylase inhibitor Ro 4-4602 on prolactin release; inhibition by l-dopa, metergoline, methysergide and 2-Br-alpha-ergocryptine Acta Endocrinologica 84(1): 36-44
Geissbuhler, F.; Eisenring, J.J.; Friedli, P.; Bartholini, G.; Tissot, R. 1972: Cerebral and peripheral L-dopa uptake in patients with parkinsonian, depressive or manic syndromes administered L-dopa by perfusion combined or not with a decarboxylase inhibitor. Pharmacological effects L'Encephale 61(2): 127-148
Christiani, K.; Möller, W.D. 1973: Drug therapy of Parkinson's syndrome. Clinical long-term study using L-dopa and the drug conbination L-dopa-decarboxylase inhibitor Münchener Medizinische Wochenschrift 115(16): 711-713
Stammler, A.; Vielhaber, K. 1972: Therapy of Parkinsonism using L-dopa in combination with a decarboxylase inhibitor Fortschritte der Neurologie Psychiatrie und Ihrer Grenzgebiete 40(10): 564-568
Fischer, P.A.; Schneider, E.; Jacobi, P.; Maxion, H. 1973: Combination therapy of Parkinson's syndrome using L-dopa and a decarboxylase inhibitor Die Medizinische Welt 24(45): 1742-1746
Malacrida, A.; Cima, L.; Gasperi, G.; Grigolo, A. 1974: Studies on the activity of the enzyme DOPA decarboxylase in Musca domestica L Italian Journal of Biochemistry 23(1): 12-18
Matussek, N.; Benkert, O.; Schneider, K.; Otten, H.; Pohlmeier, H. 1970: Effect of a decarboxylase inhibitor (Ro 4-4602) in combination with L-dopa on inhibited depressions Arzneimittel-Forschung 20(7): 934-935
De Divitiis, E.; Cerillo, A.; Tata, M.R.; Decina, A. 1973: Therapeutic association of L-dopa and an inhibitor of peripheral decarboxylase in Parkinsonism. Preliminary results Acta Neurologica 28(2): 208-212
Wajsbort, J.; Hemli, J.A.; Alfandary, I.; Yahel, M.; Siegfried, J. 1971: Clinical studies on the treatment of parkinsonism with the L-dopa and decarboxylase inhibitor Ro-4-4602 association Wiener Medizinische Wochenschrift 121(42): 741-745
Eisenlohr, J.J.; Gehlen, W. 1974: Long-term study on the anti-rigidity effect of L-dopa and a decarboxylase inhibitor (ro 8-0576) Münchener Medizinische Wochenschrift 116(28): 1353-1356
Watanabe, A.M.; Judy, W.V.; Cardon, P.V. 1974: Effect of L-DOPA on blood pressure and sympathetic nerve activity after decarboxylase inhibition in cats Journal of Pharmacology and Experimental Therapeutics 188(1): 107-113
Sakakura, C.; Takemura, M.; Miyagawa, K.; Fukuda, K.-i.; Shimomura, K.; Kin, S.; Nakase, Y.; Kuriu, Y.; Nakashima, S.; Yoshikawa, T.; Ueda, Y.; Fujiyama, J.; Sonoyama, T.; Okazaki, Y.; Hayashizaki, Y.; Hagiwara, A.; Yamagishi, H. 2004: Utility of dopa decarboxylase as a novel marker for the detection of peritoneal micro-metastases of gastric cancer with realtime RT-PCR Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(11): 1906-1908
Eisenlohr, J.J.; Gehlen, W. 1975: Changes of blood pressure, pulse and electrolytes following long-term treatment of Parkinsonism using Ro 8-0576 (L-Dopa and decarboxylase inhibitor) Der Nervenarzt 46(3): 128-135
Rabadeau Dumas, J.L.; Rondot, P.; Cardon, P. 1977: Development of studies on the treatment of parkinsonian syndromes with levodopa. II. Long-term effects of L-DOPA alone or in combination with a decarboxylase inhibitor Therapie 32(2): 161-172
Yamori, Y.; De Jong, W.; Yamabe, H.; Lovenberg, W.; Sjoerdsma, A. 1972: Effects of L-dopa and inhibitors of decarboxylase and monoamine oxidase on brain noradrenaline levels and blood pressure in spontaneously hypertensive rats Journal of Pharmacy and Pharmacology 24(9): 690-695
Gazdar, A.F.; Helman, L.J.; Israel, M.A.; Russell, E.K.; Linnoila, R.I.; Mulshine, J.L.; Schuller, H.M.; Park, J.G. 1988: Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin Cancer Research 48(14): 4078-4082